Dr. Kumar on Defining Multiple Myeloma

Video

In Partnership With:

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Shaji Kumar, MD, professor of Medicine, Mayo Clinic, gives an overview on the expanded definition of multiple myeloma.

Multiple myeloma that requires treatment, Kumar explains, is when organ damage such as high calcium, bone disease, anemia, and/or kidney issues occur. However, the definition of multiple myeloma has been expanded to include biomarkers that predict for development of these characteristics. It has also been expanded to include patients who have more than 60% of plasma cells in their bone marrow, have a free light chain ratio of more than 100, or have one or more lesions found on MRI or PET scans.

Researchers have determined that among patients who harbor one of these characteristics, the risk of having symptomatic or active multiple myeloma in 2 years is over 80%. Thus, it may be more beneficial to treat these patients earlier, Kumar says.

Related Videos
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD